We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+14.24%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.19B
AUM Growth
-$189M
Cap. Flow
-$471M
Cap. Flow %
-21.5%
Top 10 Hldgs %
25.76%
Holding
204
New
59
Increased
25
Reduced
88
Closed
32

Top Buys

Rank Stock Value
1
SEDG icon
SolarEdge
SEDG
+$41.5M
2
ILMN icon
Illumina
ILMN
+$40.9M
3
QDEL icon
QuidelOrtho
QDEL
+$34.1M
4
CIVI
Civitas Resources
CIVI
+$18.5M
5
FMC icon
FMC
FMC
+$17.3M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$245M
2
AAPL icon
Apple
AAPL
+$85.6M
3
BMY icon
Bristol-Myers Squibb
BMY
+$56.2M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$40.7M
5
CPAY icon
Corpay
CPAY
+$40.2M

Sector Composition

Rank Sector Weight
1 Technology 18.91%
2 Consumer Discretionary 12.94%
3 Healthcare 12.41%
4 Communication Services 8.9%
5 Industrials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WABC icon
201
Westamerica Bancorp
WABC
$1.35B
– –
-231,467
Closed -$10M
XYZ
202
Block Inc
XYZ
$47.5B
– –
-39,695
Closed -$1.76M
WRK
203
DELISTED
WestRock Company
WRK
– –
-150,223
Closed -$5.38M
5 6 7 8
9

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Invenomic Capital Management held 204 positions worth $2.19B, down 7.9% from $2.38B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management withdrew a net $471M in Q4 2023, closing 32 positions and reducing 88 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $245M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Invenomic Capital Management opened a new position in SolarEdge worth $42.6M.

  • Invenomic Capital Management's largest Q4 2023 buy was SolarEdge: 455,600 shares worth $42.6M.
  • Invenomic Capital Management added most to IPG Photonics in Q4 2023, an estimated $11.6M increase.
  • Invenomic Capital Management's biggest Q4 2023 reduction was Corpay, cutting an estimated $40.2M.
  • Invenomic Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2023, selling an estimated $245M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $2.19B portfolio in Q4 2023.
  • Invenomic Capital Management opened 59 new positions and closed 32 in Q4 2023.
  • Invenomic Capital Management's portfolio value fell 7.9% quarter-over-quarter to $2.19B.

Based on Invenomic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.